• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: drug

  • Heart Failure Drug Prevents Renal Damage?
    • in Cardiovascular
    • — 13 Apr, 2008

    Heart Failure Drug Prevents Renal Damage?

    Barry Massie
    Barry Massie

    Barry Massie, San Francisco VA Medical Center
    COMMENT: Aaron Kugelmass, Henry Ford Hospital, Detroit
    The adenosine A1-receptor antagonist rolofylline appears to prevent renal impairment and improve acute heart failure symptoms. Barry Massie and Aaron Kugelmass discussed
    …
    Read more
    Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors
    • in General Medicine
    • — 17 Mar, 2008

    Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors

    Silvia Novello
    Silvia Novello

    SILVIA NOVELLO, University of Turin
    Future improvements in drug treatment of lung cancer may be made by inhibiting more than one tyrosine kinase simultaneously. So said Silvia Novello when she presented data on a range of drugs
    …
    Read more
  • Audio Journal of Oncology in Advance – March 15th, 2008
    • in Oncology
    • — 16 Mar, 2008

    Audio Journal of Oncology in Advance – March 15th, 2008

    Volume 16 Number 6 (March 15th, 2008) reporting from:
    4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
    American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
    Chemotherapy Foundation Symposium, November 7-10, 2007, New York

    David Maloney
    David Maloney

    Nonmyeloablative

    …
    Read more
    “Total Therapy” Possible Cure For Multiple Myeloma?
    • in Oncology
    • — 26 Feb, 2008

    “Total Therapy” Possible Cure For Multiple Myeloma?

    Bart Barlogie
    Bart Barlogie

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    BART BARLOGIE, University of Arkansas, Little Rock
    A treatment known as “total therapy” could cure many patients with multiple myeloma, conference-goers have just heard. The targeted
    …
    Read more
  • Chronic Lymphocytic Leukemia After Fludarabine Failure
    • in News · Oncology
    • — 26 Feb, 2008

    Chronic Lymphocytic Leukemia After Fludarabine Failure

    John Gribben
    John Gribben

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    JOHN GRIBBEN, Bartholemews Hospital, London
    New promise for treating chronic lymphocytic leukemia is arising from combining antibody therapies rituximab and alemtuzumab with new drugs such as
    …
    Read more
    Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer
    • in Oncology
    • — 15 Feb, 2008

    Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

    David Cunningham
    David Cunningham
    REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    DAVID CUNNINGHAM, Royal Marsden Hospital, London
    The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer
    …
    Read more
  • Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
    • in General Medicine
    • — 4 Jan, 2008

    Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

    Peter Tyrer
    Peter Tyrer

    REFERENCE: Lancet 371:57 January 5, 2008
    PETER TYRER, Imperial College, W6 8RP London
    A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
    …
    Read more
    New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
    • in Oncology
    • — 15 Dec, 2007

    New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

    Jose Baselga
    Jose Baselga

    JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
    RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and
    …
    Read more
  • New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
    Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
    • in Cardiovascular
    • — 5 Nov, 2007

    Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

    Laura Mauri
    Laura Mauri
    Raymond Gibbons
    Raymond Gibbons

    REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts
    COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota

    The largest study to date looking
    …
    Read more
  • Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
    • in Cardiovascular
    • — 5 Nov, 2007

    Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results

    REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    LESLEE SHAW, Emory University, Atlanta
    COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson

    Some patients with stable angina may be best …

    Read more
    London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007
    • in London School of Hygiene & Tropical Medicine · Public Health
    • — 31 Aug, 2007

    London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007

    Philippe Mayaud
    Philippe Mayaud

    Herpes Simplex Therapy Reduces HIV Activity in Co-Infected Patients

    REFERENCE: N Engl J Med 2007; 356: 790-9
    PHILIPPE MAYAUD, London School of Hygiene and Tropical Medicine
    It is possible to reduce HIV activity in patients who are co-infected
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: drug

© COPYRIGHT 2020 AUDIOMEDICA.COM.